New developments in the management of neurocysticercosis

Journal of Infectious Diseases

Volumn 199, Issue 9, 2009, Pages 1261-1262

  White, A Clinton ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT;

COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; EPILEPSY; HUMAN; HYDROCEPHALUS; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SEIZURE; SERODIAGNOSIS;

ANIMALS; ANTICONVULSANTS; EMIGRATION AND IMMIGRATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEUROCYSTICERCOSIS; SEIZURES; TAENIA SOLIUM; UNITED STATES;

EID: 65649087835     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597758     Document Type: Editorial

References (12)

1. Garcia HH, Wittner M., Coyle CM, Tanowitz HB, White AC Jr. Cysticercosis. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens, and practice. Vol 2. Philadelphia, PA: Churchill-Livingstone, 2006:1289-303.
2. Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001; 57:177-83.
3. Proano-Narvaez JV, Meza-Lucas A, Mata-Ruiz O, Garcia-Jeronimo RC, Correa D. Laboratory diagnosis of human neurocysticercosis: double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay. J Clin Microbiol 2002; 40: 2115-8.
4. Garcia HH, Evans CA, Nash TE, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002; 15:747-56.
5. Nash TE, Singh G, White AC, et al. Treatment of neurocysticercosis: current status and future research needs. Neurology 2006; 67:1120-7.
6. Rangel-Castilla L, Serpa JA, Gopinath SP, Graviss EA, Diaz-Marchan PJ , White AC Jr. Contemporary neurosurgical approaches to neurocysticercosis. Am J Trop Med Hyg 2009; 80:373-8.
7. Rajshekhar V. Albendazole therapy in patients with solitary cerebral cysticercus granuloma: is it effective? J Neurol Neurosurg Psychiatry 2008; 79:238-9.
8. Del Brutto OH, Roos KL, Coffey CS, Garcia HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006; 145:43-51.
9. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004; 350:249-58.
10. Carpio A, Kelvin EA, Bagiella E, et al. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2008; 79:1050-5.
11. Rodriguez S, Dorny P, Tsang VCW, et al. Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. Cysticercosis Working Group in Peru. J Infect Dis 2009; 199:1345-52 (in this issue).
12. Fleury A, Hernandez M, Avila M, et al. Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis. J Neurol Neurosurg Psychiatry 2007; 78:970-4.